Kras Cancer Connect Inc
Public records show a registered, tax-exempt organization in good standing.
What it says it does
To empower people affected by KRAS and other RAS cancers through education advocacy and resources that connect patients with research and community helping them advocate for their best survivorship and ensuring no one faces cancer alone.
- Income
- $175,857
- Spending
- $296,025
- Reserves
- 10.6 months of spending
- Largest source of income
- donations and private grants, 100%
- Highest pay
- $42,549, founder director
Source: Form 990EZ for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Financial health
Fair: 69 out of 100. Higher than 35% of charities in its peer group (diseases, under $250k).
Reserves
28 of 35Spendable reserves would cover 10.6 months of spending.
Debt
20 of 20It owes 4% of what it owns.
Living within its means
0 of 15Spending exceeded income by 68% of income.
Source: Form 990EZ for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Governance
This organization files the short tax form, which does not ask about boards, policies or audits. That is normal for a small charity and is not a mark against it.
Source: Form 990EZ for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Impact evidence
Describes programs. Its tax return describes what it does but we have found no measurable results in it.
Programs described in its return (3)
- $145,000 spent. IIn 2024 KRAS Cancer Connect d b a KRAS Kickers invested deeply in professional conference engagement and advocacy to ensure that patients with KRAS and other RAS cancers were represented at the highest levels of oncology. As members and participants in leading professional societies including ASCO AACR SITC and IASLC we were recognized as a consistent trusted voice for the KRAS community. Within these arenas the KRAS Kickers name has become synonymous with patient empowerment: when research leaders clinicians or industry stakeholders discuss KRAS they know our community is present.Our Director and volunteers attended these conferences not to recruit patients but to educate build awareness and break down barriers between science and survivorship. We participated in poster sessions roundtables and networking events always bringing the voice of patients directly into the research ecosystem. These engagements ensured that trial designers pharmaceutical partners and oncologists heard first-hand the needs and priorities of patients navigating KRAS and other RAS mutations. At the same time we distilled new insights into plain-language educational updates and shared them widely through Facebook groups newsletters YouTube sessions and open community forums.We also developed and distributed thousands of reviewed educational materialsbooklets postcards stickers and conference handoutsthat carried accurate accessible information about KRAS and RAS cancers. These were conversation starters and learning tools designed to empower patients and their families in clinic visits and community discussions. Our advocacy extended through cross-nonprofit collaborations where we joined forces with partner organizations to amplify shared goals in biomarker awareness equitable access to research and survivorship support. Together we raised visibility for RAS cancers across multiple disease communities and elevated the patient perspective in conversations that shape the future of oncology.This program area represented approximately $145,000 in 2024 program spending and its impact was visible in both directions: the oncology community increasingly views KRAS Kickers as the trusted patient bridge in RAS discussions and patients everywhere benefit from timely accessible information and resources that help them advocate for their best survivorship.
- $79,000 spent. KRAS Cancer Connect d b a KRAS Kickers hosted open-access webinars where leading clinicians and researchers spoke directly with patients. These sessions gave participants the rare opportunity to hear from experts at the cutting edge of oncology and to ask questions in real time. Our role was to ensure those answers did not remain locked in scientific jargon but were translated into clear practical insights that patients and families could apply to their own care.We emphasized not just what to ask but what to listen forhow to recognize key details map choices within a decision-tree of options and apply that understanding in conversations with ones own doctor. Researchers frequently remarked on the depth of understanding and curiosity shown by our community; patients were not passive recipients of information but engaged partners shaping informed decisions for life while living with cancer.Beyond virtual sessions we organized onsite lab visits at Johns Hopkins and Moffitt Cancer Center where patients observed science in action met investigators and asked candid questions about research. We also convened a KRAS Kickers community event in Charlotte NC building connection and confidence as people navigated rapidly evolving options. These experiences demystified the research process reduced barriers to understanding clinical trials and helped patients see themselves as active participants in the research ecosystem rather than passive recipients of care. Our separate peer support group remains private and unrecorded to protect confidentiality.Approximately $79,000 supported expert speakers platforms and tools moderator support travel and content development in 2024. These efforts advanced survivorship through education and empowerment closing gaps in understanding and accesswhat our community calls KRAS holesso no one faces cancer alone.
- $15,500 spent. KRAS Cancer Connect d b a KRAS Kickers believes patients lived experience is as valuable as scientific expertise. In 2024 we provided stipends to patients participating in scientific and medical meetings recognizing both the financial burden of treatment appointments and the value of their time and insights. These stipends ensured patients could engage fully in education and advocacy without additional hardshipand more importantly affirmed that their contributions matter.We also supported moderators and peer leaders with stipends for sustaining our community: sharing updates from conferences and webinars translating research into plain language guiding discussions and ensuring accuracy across channels. This created a vital looppatients attend and learn; moderators communicate and amplify; the wider community receives timely trustworthy information.No clinicians or researchers were paid or provided honoraria. We flipped the script by investing directly in patients and peer leadership centering the people most affected by KRAS and other RAS cancers. Approximately $15,000 supported stipends and modest speaker expenses where applicable in 2024 strengthening patient leadership consistent knowledge flow and a culture that eliminates gaps and KRAS holes in care.
Source: Form 990EZ for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Legitimacy checks
Is it registered with the IRS? Passed.
Listed in the IRS master file of tax-exempt organizations as a 501(c)(3) charitable organization.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated September 7, 2026.
Has the IRS revoked its tax-exempt status? Passed.
Not on the IRS automatic revocation list.
Source: Automatic revocation of exemption list, Internal Revenue Service, file dated September 30, 2026.
Are donations tax-deductible? Passed.
On the IRS list of organizations eligible to receive tax-deductible contributions.
Source: Publication 78 data: organizations eligible for tax-deductible contributions, Internal Revenue Service, file dated September 10, 2026.
Is it keeping up with its IRS filings? Passed.
Most recent return on file covers the year ending December 2024.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated September 7, 2026.
How long has it been tax-exempt? Passed.
Recognized by the IRS since October 2023.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated September 7, 2026.
Is it in good standing with state regulators? Passed.
Not on California's list of charities barred from soliciting. Other states are not yet checked.
Source: May Not Operate or Solicit for Charitable Purposes list, California Attorney General, Registry of Charities and Fundraisers, file dated October 7, 2026.
Ratings and checks are our reading of public records, using the published method. They are not a statement about anyone's honesty. If you work for this organization, you can send corrections or results, confirm you want gifts through Veridonate, or ask to be removed from giving.